NASDAQ:ALLO

Allogene Therapeutics Stock Predictions

etoro logo Buy ALLO
*Your capital is at risk
$2.00
-0.0500 (-2.44%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLO Prediction Chart

ALLO Predictions History

Latest community submissions for ALLO.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 22, 2025 $1.08 -3.38% $1.19 X 90.94% 0
Aug 22, 2025 $1.10 -2.11% $1.19 X 92.13% 0
Aug 22, 2025 $1.20 +7.14% $1.19 V 99.16% 3
Aug 19, 2025 $1.15 +5.50% $1.05 X 90.48% 0
Aug 18, 2025 $1.06 -3.72% $1.09 V 97.16% 1
Aug 18, 2025 $1.07 -2.33% $1.09 V 98.57% 2
Aug 18, 2025 $1.14 +3.64% $1.09 X 95.41% 0
Aug 15, 2025 $1.03 -3.72% $1.10 X 93.65% 0
Aug 15, 2025 $1.05 -2.32% $1.10 X 95.01% 0
Aug 15, 2025 $1.08 +0.93% $1.10 V 98.18% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLOGENE THERAPEUTICS INC.
Allogene Therapeutics
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE